Qianhai Health Holdings Limited (00911.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.5x

Market Cap

HKD 79.49M

MomentumView details →

1D Return

−4.08%

YTD Return

+70.91%

RSI (14)

35.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.5x

Market Cap

HKD 79.49M

RSI (14)

35.8

MomentumView details →

1D Return

−4.08%

YTD Return

+70.91%

ProfitabilityView details →

Gross Margin

1.16%

Net Margin

−0.94%

EBITDA Margin

0.87%

ROE (TTM)

−1.99%

ROA (TTM)

−1.78%

Asset Turnover

1.97x

GrowthView details →

Revenue YoY

−58.78%

EPS YoY

+97.30%

FCF YoY

+125.99%

Revenue CAGR 3Y

−29.85%

EPS CAGR 3Y

+355.84%

EBITDA YoY

+102.70%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

8.92x

Quick Ratio

2.96x

Div Yield

—

Div Rate

—

Div Growth 1Y

−97.22%

Financials snapshotView financials →

Revenue (TTM)

836.18M

Net Income (TTM)

−7.84M

Op. CF (TTM)

49.27M

Latest newsMore news →

Qianhai Health Holdings reported interim results for the six months ended June 2026, with revenue of HKD 116.76 million, down 65.8% year-on-year, and net profit of HKD 2.844 million, down 40.4% year-on-year.23d ago

Similar companies

InterCure Ltd.INCR Huakang Biomedical Holdings Company Limited08622.HK AlvotechALVOW Talphera, Inc.TLPH Cumberland Pharmaceuticals Inc.CPIX Procaps Group S.A.PROC Find similar companies →

Latest newsMore news →

Qianhai Health Holdings reported interim results for the six months ended June 2026, with revenue of HKD 116.76 million, down 65.8% year-on-year, and net profit of HKD 2.844 million, down 40.4% year-on-year.23d ago